MetaCap

Baxter International (BAX) vs Solventum (SOLV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Baxter International (BAX) has outperformed Solventum (SOLV) over the past year, gaining 38.7% versus a gain of 1.9%. Solventum is the larger company by market cap ($14.36 billion vs $13.14 billion), about 1.1 times the size, while Baxter International is growing revenue faster (+5.7% vs +0.9%). On valuation, Solventum trades at a lower forward P/E (11.2x vs 12.4x for Baxter International).

Baxter International pays a dividend yielding 0.16%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus -8.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BAX+38.67%SOLV+1.93%
+59%+15%-29%
Nov 21, 20251 yearNov 20, 2026
BAX-40.59%SOLV+21.50%
+37%-15%-67%
Mar 25, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BAX versus SOLV key metrics
MetricBAXSOLV
Share price$25.39$84.50
Market cap$13.14B$14.36B
1-day change0.00%-1.52%
YTD return+32.86%+6.64%
1-year return+38.67%+1.93%
5-year return-66.72%—
P/E ratio (TTM)—94.94
Forward P/E12.4111.20
EPS (TTM)$-1.21$0.89
Dividend yield0.16%0.00%
Annual dividend$0.04$0.00
Revenue (latest FY)$11.24B$8.32B
Revenue growth (YoY)+5.72%+0.86%
Net income (latest FY)$-957.00M$1.56B
Gross margin30.05%53.47%
Operating margin-2.74%26.20%
Net margin-8.51%18.69%
52-week high$30.00$94.16
52-week low$15.73$62.38
Distance from 52-week high-15.37%-10.26%
Analyst consensusholdbuy
Avg. price target upside+7.33%+16.43%
Average volume6.38M1.03M
Shares outstanding517.35M169.96M
Employees37,50020,584
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BAX has outperformed SOLV by 36.7 percentage points over the past year.
  • Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus -8.5 cents for Baxter International.

About Baxter International

BAX stock →

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.

Health Care · Medical/Dental Instruments · 37,500 employees

About Solventum

SOLV stock →

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.

Health Care · Medical/Dental Instruments · 20,584 employees

BAX vs SOLV FAQ

Which is bigger, Baxter International or Solventum?

Solventum (SOLV) is larger, with a market capitalization of $14.36B compared with $13.14B for Baxter International (BAX).

Which stock has performed better over the past year, BAX or SOLV?

BAX returned +38.67% over the past 12 months, compared with +1.93% for SOLV (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Baxter International or Solventum?

Baxter International pays a dividend yielding 0.16%, while Solventum does not currently pay a regular dividend.

Are Baxter International and Solventum in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons